Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership

The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2017-05, Vol.101 (5), p.622-624
Main Authors: Dive, C, Shishido, SN, Kuhn, P
Format: Article
Language:English
Subjects:
Atlases as Topic
Biomarkers, Tumor - blood
Biopsy
Genomics
Humans
Neoplasm Metastasis
Neoplasms - diagnosis
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood sample to identify early those patients whose cancer has returned, while analyzing circulating tumor cells (CTCs) in great detail, providing new clues on the most effective therapy for the patient's cancer.
ISSN:0009-9236
1532-6535
DOI:10.1002/cpt.657